Silence Therapeutics Plc (SLN)
6.37
+0.14
(+2.25%)
USD |
NASDAQ |
Dec 19, 16:00
6.33
-0.04
(-0.63%)
After-Hours: 20:00
Silence Therapeutics EPS Diluted (Quarterly): -0.441 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | -0.2955 |
| Adaptimmune Therapeutics Plc | -0.1163 |
| Mereo BioPharma Group Plc | -0.0436 |
| NuCana Plc | -0.1348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.83M |
| Revenue (Quarterly) | 0.158M |
| Total Expenses (Quarterly) | 20.99M |
| Enterprise Value | 198.87M |
| Gross Profit Margin (Quarterly) | -12.91% |
| Profit Margin (Quarterly) | -13.18K% |
| Earnings Yield | -37.35% |
| Normalized Earnings Yield | -37.04 |